DKK2 and neoplasm: DKK2 blockage showed a stronger effect on tumor suppression than this sub-optimal dose of anti-VEFGR (Supplementary Fig. 5A–B) and extended survival (Fig. 5A & Supplementary Fig. 5C–D).